Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Gregorio Marañón (9)

2023

  1. Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model (Frontiers in Pharmacology, (2023), 14, (1021535), 10.3389/fphar.2023.1021535)

    Frontiers in Pharmacology

  2. Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model

    Frontiers in Pharmacology, Vol. 14

  3. Relevance of [18F]FDG-PET/CT in the detection of colon pathology in patients studied by bacteriemia or infectious endocarditis caused by enteropathogenic microorganisms

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 139-146

2021

  1. Human influenza A virus causes myocardial and cardiac-specific conduction system infections associated with early inflammation and premature death

    Cardiovascular research, Vol. 117, Núm. 3, pp. 876-889

  2. Prevalence of biliary acid malabsorption in patients with chronic diarrhoea of functional characteristics: a prospective study

    BMC Gastroenterology, Vol. 21, Núm. 1

2020

  1. Probiotic Bifidobacterium breve prevents DOCA-salt hypertension

    FASEB Journal, Vol. 34, Núm. 10, pp. 13626-13640

2019

  1. Vascular smooth muscle cell-specific progerin expression in a mouse model of Hutchinson–Gilford progeria syndrome promotes arterial stiffness: Therapeutic effect of dietary nitrite

    Aging Cell, Vol. 18, Núm. 3

2018

  1. Pulmonary Arterial Hypertension Affects the Rat Gut Microbiome

    Scientific Reports, Vol. 8, Núm. 1

2016

  1. Effects of quercetin in a rat model of hemorrhagic traumatic shock and reperfusion

    Molecules, Vol. 21, Núm. 12